PMID: 24593045

Marson FA, Bertuzzo CS, Ribeiro AF, Ribeiro JD
Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study.
BMC Med Genet. 2014 Mar 4;15:27. doi: 10.1186/1471-2350-15-27., [PubMed]
Sentences
No. Mutations Sentence Comment
47 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24593045:47:189
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 24593045:47:182
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 24593045:47:200
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 24593045:47:167
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 24593045:47:174
status: NEW
view ABCC7 p.Arg1162* details
CFTR mutation identification CFTR mutation identification was performed by polymerase chain reaction (PCR) for F508del and the fragment-length polymorphism method for G542X, R1162X, R553X, G551D, and N1303K mutations. Login to comment
48 ABCC7 p.Ile618Thr
X
ABCC7 p.Ile618Thr 24593045:48:149
status: NEW
view ABCC7 p.Ile618Thr details
Some CF mutations were identified by sequencing or Multiplex Ligation-dependent Probe Amplification (MLPA) analysis: S4X, 2183A > G, 1717-G > A, and I618T. Login to comment
51 ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 24593045:51:72
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Pro205Ser
X
ABCC7 p.Pro205Ser 24593045:51:62
status: NEW
view ABCC7 p.Pro205Ser details
All class I, II or III mutations, but not class IV mutations (P205S and R334W), identified were included in statistical analysis. Login to comment
121 ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 24593045:121:609
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 24593045:121:586
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 24593045:121:540
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 24593045:121:671
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 24593045:121:692
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 24593045:121:712
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 24593045:121:778
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 24593045:121:563
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 24593045:121:677
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 24593045:121:736
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 24593045:121:743
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 24593045:121:794
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Ile618Thr
X
ABCC7 p.Ile618Thr 24593045:121:698
status: NEW
view ABCC7 p.Ile618Thr details
An analysis of genotypic combinations for GSTM1 and GSTP1 polymorphic loci showed that changes in GSTP1 activities Table 3 Genotyping of GCLC, GSTM1, GSTT1, and GSTP1 polymorphisms and CFTR mutations Gene Chromosomal position Location Polymorphism MAF HWE p-valuea GCLC, rs17883901 6p12 Promoter region C > T 0.12 9.97 <0.005 GCLC, rs137852340 6p12 Promoter region A > G 0.19 0.04 >0.05 GSTP1, rs1695 11q13 Exon A > G 0.25 1.11 >0.05 GSTM1 1p13.3 Deletion GSTT1 22q11.23 Deletion CFTR mutation N Frequency F508del/F508del 57 31.67% F508del/G542X 12 6.67% F508del/R1162X 5 2.78% F508del/N1303K 4 2.22% F508del/R553X 1 0.56% F508del/S4X 1 0.56% F508del/1717-1G > A 1 0.56% G542X/R1162X 1 0.56% G542X/I618T 1 0.56% G542X/2183A > G 1 0.56% R1162X/R1162X 1 0.56% F508del/- 45 25.00% G542X/- 5 2.78% R1162X/- 1 0.56% -/- 44 24.45% MAF, Minor allele frequency; HWE, Hardy Weinberg Equilibrium; a P-value for Hardy-Weinberg Equilibrium; N, Number of patients; -, No identified CFTR mutation. Login to comment